MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure

Liver International

Volumn 27, Issue 3, 2007, Pages 329-334

  Katoonizadeh, Aezam ^a   Decaestecker, Jochen ^a   Wilmer, Alexander ^a   Aerts, Raymond ^a   Verslype, Chris ^a   Vansteenbergen, Werner ^a   Yap, Paul ^a   Fevery, Johan ^a   Roskams, Tania ^a   Pirenne, Jacques ^a   Nevens, Frederik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Acute liver failure; Clichy criteria; Hepatic encephalopathy; King's College Hospital criteria; Liver transplantation; MELD score

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMFEPRAMONE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ASPARAGINASE; AZITHROMYCIN; DEXFENFLURAMINE; ETHAMBUTOL PLUS ISONIAZID; HERBACEOUS AGENT; IBUPROFEN; ISONIAZID; NIMESULIDE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANOPHOSPHATE; PARACETAMOL; RIFATER; SALAZOSULFAPYRIDINE; TETRACHLOROETHYLENE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; AMANITA PHALLOIDES; ARTICLE; AUTOIMMUNE HEPATITIS; BRAIN EDEMA; BUDD CHIARI SYNDROME; DIAGNOSTIC VALUE; DISEASE EXACERBATION; FATTY LIVER; FEMALE; HELLP SYNDROME; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS B; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LIVER FAILURE; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION; WILSON DISEASE;

ADULT; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33947262123     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01429.x     Document Type: Article

References (35)

1. Shakil AO, Kramer D, Mazariegos JV, Fung J, Rakela J. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transplant 2000; 6: 163-9.
2. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. Hepatology 2004; 40: 192-7.
3. Riorden S, Williams R. Mechanism of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 2003; 23: 203-16.
4. Dhiman R, Seth A, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminate hepatic failure by multivariate analysis. Dig Dis Sci 1998; 43: 1311-6.
5. Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver failure. Hepatology 2005; 41: 26-31.
6. Neuberger J. Prediction of survival for patients with fulminant hepatic failure. Hepatology 2005; 41: 19-22.
7. Bernuau J, Goudau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis. Hepatology 1986; 6: 648-51.
8. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
9. Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transplant 2000; 6: 170-3.
10. Pauwels A, Mostefa-Kara N, Florent C, Levy V. Emergency liver transplantation for acute liver failure: Evaluation of London and Clichy criteria. J Hepatol 1993; 17: 124-7.
11. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: An assessment of King's college Criteria. Hepatology 1997; 26: 62-68.
12. Lee WM. Acute liver failure in united state. Semin Liver Dis 2003; 23: 217-26.
13. Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: Relation to other prognostic indicators. Gut 1992; 33: 98-102.
14. Harrison PM, O'Grady JG, Keays RT, Alexander GJ, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. Br Med J 1990; 301: 964-6.
15. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure. Lancet 2002; 359: 558-63.
16. Schmidt L, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminohen-induced hepatotoxicity. Hepatology 2002; 36: 659-65.
17. Dabos KJ, Newsome P, Parkinson JA, et al. Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Liver Transplant 2004; 77: 200-5.
18. Bernal W, Wendon J. More on serum phosphate in acute liver failure. Hepatology 2003; 38: 533-4.
19. Khee Lim NG, Davidson JS, Bathgate AJ. Serum phosphate is not a reliable early predictor of outcome in paracetamol induced hepatotoxicity. Liver Transplant 2004; 10: 158-9.
20. Rolando N, Wade J, Davalos M, Wendon J, Howard JP, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-9.
21. Chung PY, Citrin MD, Te HS. Serum phosphorous level predicts clinical outcome in fulminate hepatic failure. Liver Transplant 2003; 9: 248-53.
22. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transplant 2004; 10: 1018-23.
23. Stephen M, Williams R. Cause and prognosis in acute liver failure. Liver Transplant Surg 1999; 5: 86-9.
24. Hadem J, Stifel P, Fifai K, Schneider A, Wedemeyer H, Manns MP. Combining baseline bilirubin, lactate and aetiology in patients with acute liver failure is superior to King's College criteria in predicting transplantation or death. Hepatology 2005; 42: C52.
25. Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: Relation to other prognostic indicators. Hepatology 1993; 18: 1370-6.
26. Onaca NN, Levy MF, Sanchez EQ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transplant 2003; 9: 117-23.
27. Kremers WK, Ijperen MW, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004; 39: 764-79.
28. Yantorno SET, Trentadue JJ, Ruf AE, et al. The model for end stage liver disease (MELD): A useful tool to assess prognosis in fulminant hepatic failure. Liver Transplantation 2004; 10: C36.
29. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining syndromes. Lancet 1993; 342: 273-5.
30. Vaquero J, Blei AT. Etiology and management of fulminant hepatic failure. Curr Gastroenterol Rep 2003; 5(1): 39-47.
31. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transplant 2005; 11: 594-60.
32. Zaman MB, Hoti E, Qasim A, et al. MELD Score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplant Proc 2006; 38: 2097-8.
33. Rossaro L, Chambers CC, Polson J, et al. Performance of MELD in predicting outcome in acute liver failure. Gastroenterology 2005; 128: S1492.
34. Pelaez-Luna M, Martinez-Salgado J, Olivera-Martinez MA. Utility of the MAYO end-stage liver disease score, King's college criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transplant Proc 2006; 38: 927-9.
35. Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T. Liver regeneration in acute severe liver impairment: A clinicopathological correlation study. Liv Int 2006; 26: 1225-33.